- Home
- BLIN vs BOLT Comparison
BLIN vs BOLT Comparison
Compare BLIN & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLIN
- BOLT
- Stock Information
- Founded
- BLIN 2000
- BOLT 2015
- Country
- BLIN United States
- BOLT United States
- Employees
- BLIN N/A
- BOLT N/A
- Industry
- BLIN EDP Services
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- BLIN Technology
- BOLT Health Care
- Exchange
- BLIN Nasdaq
- BOLT Nasdaq
- Market Cap
- BLIN 15.0M
- BOLT 16.8M
- IPO Year
- BLIN 2007
- BOLT 2021
- Fundamental
- Price
- BLIN $1.92
- BOLT $0.40
- Analyst Decision
- BLIN Strong Buy
- BOLT Hold
- Analyst Count
- BLIN 1
- BOLT 5
- Target Price
- BLIN $4.62
- BOLT $1.13
- AVG Volume (30 Days)
- BLIN 60.0K
- BOLT 146.3K
- Earning Date
- BLIN 05-13-2025
- BOLT 05-13-2025
- Dividend Yield
- BLIN N/A
- BOLT N/A
- EPS Growth
- BLIN N/A
- BOLT N/A
- EPS
- BLIN N/A
- BOLT N/A
- Revenue
- BLIN $15,394,000.00
- BOLT $7,690,000.00
- Revenue This Year
- BLIN $7.71
- BOLT N/A
- Revenue Next Year
- BLIN $6.98
- BOLT $77.45
- P/E Ratio
- BLIN N/A
- BOLT N/A
- Revenue Growth
- BLIN N/A
- BOLT N/A
- 52 Week Low
- BLIN $0.76
- BOLT $0.38
- 52 Week High
- BLIN $2.80
- BOLT $1.48
- Technical
- Relative Strength Index (RSI)
- BLIN 73.04
- BOLT 40.42
- Support Level
- BLIN $1.36
- BOLT $0.38
- Resistance Level
- BLIN $1.52
- BOLT $0.47
- Average True Range (ATR)
- BLIN 0.14
- BOLT 0.04
- MACD
- BLIN 0.05
- BOLT -0.00
- Stochastic Oscillator
- BLIN 70.00
- BOLT 18.81
About BLIN Bridgeline Digital Inc.
Bridgeline Digital Inc is a AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more traffic to their websites, converting more visitors to purchasers, and increasing average order value. Company software is available through a cloud-based Software as a Service (SaaS) model. It helps to maximize the performance of critical websites, intranets, and online stores. The company generates revenue from digital engagement services, subscription, perpetual licenses, maintenance, and hosting. Geographically, it derives a majority of revenue from the United States.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.